Micro
Aftermath
Archived
ZTS stock analysis
Activity declining — narrative losing relevance.
Score
0.3
Velocity
▲ 0.0
Articles
6
Sources
1
Sentiment Timeline
Event Timeline
🤖
AI Overview
Zoetis Inc. (ZTS), a leading animal health company, has seen mixed sentiment among analysts, driving a range of price targets and recommendations.
ZTS's stock price has fluctuated, trading at $75.89 on June 22nd and $117.52 on April 22nd. Bullish theses highlight its low forward P/E of 11.10 and wide moat, with Renaissance Investment Management and Citi maintaining 'Buy' ratings. Conversely, Jim Cramer expressed concerns, stating he feels "something not well" at ZTS. Analysts' estimates and ratings vary, with some reducing price objectives while others remain optimistic.
Market impact extends to the animal health sector, with investors evaluating ZTS's growth prospects and competitive advantages. Upcoming catalysts include ZTS's Q2 earnings release on July 27th and any regulatory updates on its pipeline products. Additionally, investors should monitor the broader pet care market and any shifts in demand for animal health services.
ZTS's stock price has fluctuated, trading at $75.89 on June 22nd and $117.52 on April 22nd. Bullish theses highlight its low forward P/E of 11.10 and wide moat, with Renaissance Investment Management and Citi maintaining 'Buy' ratings. Conversely, Jim Cramer expressed concerns, stating he feels "something not well" at ZTS. Analysts' estimates and ratings vary, with some reducing price objectives while others remain optimistic.
Market impact extends to the animal health sector, with investors evaluating ZTS's growth prospects and competitive advantages. Upcoming catalysts include ZTS's Q2 earnings release on July 27th and any regulatory updates on its pipeline products. Additionally, investors should monitor the broader pet care market and any shifts in demand for animal health services.
AI Overview as of Jul 01, 2026
Timeline
Last UpdatedApr 23, 2026